The great rebundling

by Silvia Saccardi 15 August 2023

The UK has signalled further divergence from the EU and its MiFID II legislative framework in the proposal to allow fund managers to rebundle payments to US broker-dealers for execution and research rules.

Under MiFID II, GPs are required to pay for investment research separately to provide greater transparency to LPs and prevent conflicts of interest. As such, GPs must pay for investment research out of their own resources or through a “research payment account”.

However, this stringent requirement resulted in a misalignment with US legislation whereby accepting a separate payment for research would qualify broker-dealers as investment advisers under the 1940 Investments Advisers Act.

Categories: AnalysisRegs & ComplianceAIFMDDomicileRegulatory update

22 February 2024

Next stop – carried interest

Liquidity event delays are having an effect on waterfall calculation models

22 February 2024

Comment: What you need to know about ELTIF 2.0

Karma Samdup and Vicki Odette, partners at Haynes & Boone, examine how ELTIF 2.0 aims to unlock private market access for retail investors

21 February 2024

LISTEN: Top of the ops: Is the grass evergreener?

A conversation with Eurazeo's Luc Maruenda on setting up evergreen fund structures

20 February 2024

A&M partners with Pactio

Partnership enhances the firm’s M&A tax advisory services with Pactio’s transaction structuring automation tools

16 February 2024

Untangling Pillar 2 implications

Pillar 2 may not mean more tax for most GPs but it could be a compliance headache

15 February 2024

Seven out of 10 fund managers received AML fines in last two years

Ocorian’s latest survey finds alternative investment firms concerned about increasing AML risks